Skip to main content

Table 1 Patient cohort: demographics

From: Native T1 mapping detects both acute clinical rejection and graft dysfunction in pediatric heart transplant patients

Demographic

All cases

Group A

Groups B and C

P value

All cases

n = 50

n = 37 (74%)

n = 13 (26%)

 

Male

64.0%

67.6%

53.8%

0.412

White

77.3%

75.8%

81.8%

0.915

Hispanic

32.0%

24.3%

53.8%

0.083

Mean age (years)

12.2 ± 4.6

11.9 ± 4.8

13.3 ± 4.2

0.326

Mean graft age (years)

5.3 ± 4.1

5.4 ± 3.7

5.1 ± 5.2

0.882

Graft ischemia time (minutes)

228 ± 44

225 ± 43

236 ± 49

0.531

Coronary vasculopathy

0%

0%

0%

1.000

Clinical concerns for rejection

4.0%

2.7%

7.7%

0.549

Indication for catheterization: surveillance

70%

75.7%

53.8%

0.191

Number of prior rejection episodes

6.3 ± 6.1

5.8 ± 6.1

7.8 ± 6.1

0.315

NT-pro BNP Level (pg/mL)

787 ± 1477

332 ± 530

1663 ± 2549

0.099

Positive for donor-specific antibodies

30.2%

20.0%

53.8%

0.051

Echo LV ejection fraction (%)

63.4 ± 5.0

64.3 ± 5.2

60.8 ± 3.4

0.009

Cath RA mean pressure (mmHg)

10 ± 4

9 ± 3

12 ± 5

0.096

Cath RV systolic (mmHg)

28 ± 5

28 ± 5

28 ± 5

0.954

Cath RVEDP (mmHg)

11 ± 4

11 ± 4

13 ± 6

0.137

Cath average RPCW/LPCW (mmHg)

12 ± 5

11 ± 3

15 ± 6

0.071

Biopsy grade > 0R

34%

16.2%

84.6%

0.001

Biopsy grade > 1R

4%

0%

15.4%

0.014

  1. NT-Pro BNP N-terminal pro-hormone brain natriuretic peptide, LV left ventricular, RV right ventricular, RVEDP right ventricular end-diastolic pressure